OTC · Biotechnology

PaxMedica, Inc. Common Stock (PXMD) Stock

$0.00 OTC: PXMD Healthcare

PaxMedica, Inc. is a biopharmaceutical company currently in the clinical development phase, dedicated to advancing anti-purinergic drug therapies (APTs).

Valuation

MetricValue
Price$0.00
Market Cap$88385
P/E Ratio0.00
P/B Ratio0.03
P/S Ratio0.00
EPS (TTM)$2.44
52-Week High$0.02
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-600.00%
ROA-370.36%
ROCE-415.56%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio0.36

Annual Financials (USD)

Metric20192020202120222023
Revenue$0$0$0$0$0
Operating Profit$-1.0M$-6.0M$-7.0M$-11.0M$-16.0M
Net Profit$-1.0M$-8.0M$-13.0M$-15.0M$-18.0M
EPS$-0.06$-13.42$-18.81$-28.73$-11.00
Op Margin—————

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$0$1.0M$1.0M$2.0M$6.0M
Total Liabilities$0$6.0M$11.0M$2.0M$2.0M
Cash$0$1.0M$0$2.0M$5.0M
Borrowings$0$1.0M$0$0$0

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$0$-2.0M$-6.0M$-6.0M$-11.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$1.0M$0$0$-1.0M
Net Cash Flow$0$1.0M$-1.0M$1.0M$3.0M
Free Cash Flow$0$-2.0M$-6.0M$-6.0M$-11.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.29
FCF Yield-12183.63%
Quick Ratio3.16
Interest Coverage-1761.59
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held0.00%
Institutions Held0.15%
Institutions Float Held0.15%
Institutional HolderSharesReport Date
Osaic Holdings Inc582024-06-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
EVLOEvelo Biosciences, Inc. $0.00 — 0.00 $1898 0.00%
HLUNHEALTHeUNIVERSE, Inc. $0.00 — 0.10 $11778 0.00%
INFIQInfinity Pharmaceuticals, Inc. $0.00 — 0.00 $9076 0.00%
NNLXNanoLogix, Inc. $0.00 — -0.01 $9569 0.00%
OZYMFStrategic Partners A/S $90.00 +0.00% -36.17 $3.72M 0.00%

About PaxMedica, Inc. Common Stock

PaxMedica, Inc. is a biopharmaceutical company currently in the clinical development phase, dedicated to advancing anti-purinergic drug therapies (APTs). These innovative treatments are specifically designed to address complex neurological disorders presenting with stubborn and persistent symptoms. The company's primary investigative drug is PAX-101, an intravenous (IV) form of suramin, which is being explored for a variety of conditions. These include autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, post-COVID-19 syndrome (commonly known as "long COVID"), and human African trypanosomiasis. Furthermore, PaxMedica is also developing PAX-102, an intranasal version of suramin, intended for various neurological applications. The company, which was incorporated in 2018 and has its headquarters in Tarrytown, New York, previously operated as Purinix Pharmaceuticals LLC before rebranding to PaxMedica, Inc. in April 2020. It functions as a subsidiary of Tardimed Sciences LLC.

PaxMedica, Inc. Common Stock (PXMD) stock trades at $0.00 with a market capitalization of $88385. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.03, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.02, and currently trades 100.0% below its 52-week high.

On profitability, PaxMedica, Inc. Common Stock generates a return on equity (ROE) of -600.00%, return on capital employed of -415.56%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.paxmedica.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides